Cullinan Therapeutics, Inc.盘中异动股价大涨5.11%

市场透视2025-05-17

北京时间2025年05月17日03时02分，Cullinan Therapeutics, Inc.（CGEM.us）股票出现波动，股价急速拉升5.11%。截至发稿，该股报7.61美元/股，成交量20.5492万股，换手率0.35%，振幅8.01%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-48.50百万美元，每股收益-0.82美元，毛利-76000.00美元，市盈率-2.74倍。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2536344130?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-17 03:02","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2536344130","market":"us","top_or_hot":-1,"title":"Cullinan Therapeutics, Inc.盘中异动 股价大涨5.11%","media":"市场透视","content":"<div>\n<p>北京时间2025年05月17日03时02分，Cullinan Therapeutics, Inc.（CGEM.us）股票出现波动，股价急速拉升5.11%。截至发稿，该股报7.61美元/股，成交量20.5492万股，换手率0.35%，振幅8.01%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-48.50百万美元，每股收益-0.82美元，毛利-76000.00美元，市盈率-2.74倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517030251a4813d15&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cullinan Therapeutics, Inc.盘中异动 股价大涨5.11%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCullinan Therapeutics, Inc.盘中异动 股价大涨5.11%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-17 03:02 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517030251a4813d15&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年05月17日03时02分，Cullinan Therapeutics, Inc.（CGEM.us）股票出现波动，股价急速拉升5.11%。截至发稿，该股报7.61美元/股，成交量20.5492万股，换手率0.35%，振幅8.01%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-48.50百万美元，每股收益-0.82美元，毛利-76000.00美元，市盈率-2.74倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517030251a4813d15&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517030251a4813d15&s=b","article_id":"2536344130","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517030251a4813d15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2536344130","pubTimestamp":1747422171,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年05月17日03时02分，Cullinan Therapeutics, Inc.股票出现波动，股价急速拉升5.11%。截至发稿，该股报7.61美元/股，成交量20.5492万股，换手率0.35%，振幅8.01%。Cullinan Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.26%。其相关个股中，Affimed N.V.、Inozyme Pharma, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Affimed N.V.、Polyrizon Ltd.、Nucana Plc较为活跃，换手率分别为5312.54%、3846.26%、1720.64%，振幅较大的相关个股有Affimed N.V.、Onconetix, Inc.、Vor Biopharma Inc.，振幅分别为466.98%、66.89%、66.82%。Cullinan Therapeutics, Inc.公司简介：Cullinan Therapeutics Inc 是一家生物制药公司。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","CGEM":"Cullinan Therapeutics","LENZ":"Therapeutics","BK4007":"制药","BK4539":"次新股"},"translate_title":"Cullinan Therapeutics, Inc. stock jumps 5.11% in intraday moves","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CGEM":1,"LENZ":1},"content_text":"北京时间2025年05月17日03时02分，Cullinan Therapeutics, Inc.（CGEM.us）股票出现波动，股价急速拉升5.11%。截至发稿，该股报7.61美元/股，成交量20.5492万股，换手率0.35%，振幅8.01%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-48.50百万美元，每股收益-0.82美元，毛利-76000.00美元，市盈率-2.74倍。机构评级方面，在所有10家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Cullinan Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.26%。其相关个股中，Affimed N.V.、Inozyme Pharma, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026(To Pur Com)涨幅较大，Affimed N.V.、Polyrizon Ltd.、Nucana Plc较为活跃，换手率分别为5312.54%、3846.26%、1720.64%，振幅较大的相关个股有Affimed N.V.、Onconetix, Inc.、Vor Biopharma Inc.，振幅分别为466.98%、66.89%、66.82%。Cullinan Therapeutics, Inc.公司简介：Cullinan Therapeutics Inc 是一家生物制药公司。它拥有多元化的临床阶段资产组合，可抑制疾病的关键驱动因素或利用免疫系统来消除肿瘤和自身免疫性疾病中的病变细胞。它对肿瘤学、免疫学和转化医学的理解创造了差异化的想法，确定了合适的目标，并选择了最佳模式来开发针对各种癌症和自身免疫适应症的变革性疗法。它有一个报告部门和一个运营部门，即开发免疫学和肿瘤疗法的业务。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2536344130","isCrawlerRequest":true}

Cullinan Therapeutics, Inc.盘中异动 股价大涨5.11%

精彩评论

Cullinan Therapeutics, Inc.盘中异动股价大涨5.11%